Related by context. Frequent words. (Click for all words.) 62 substudy 62 placebo controlled randomized 60 phase IIa 60 subgroup analyzes 60 noninferiority 59 phase IIb 59 randomized Phase III 59 DSMB 59 multicenter clinical 59 placebo controlled trials 58 unblinded 58 axitinib 57 Phase IIa trial 57 composite endpoint 57 primary efficacy endpoints 57 active comparator 57 GVAX 56 clinical endpoints 56 vandetanib 56 tesmilifene 56 randomized controlled clinical 56 #mg dose [003] 56 prespecified 56 ticagrelor 56 efficacy endpoints 56 TELCYTA 56 Phase 2b clinical 56 PROMACTA 56 Phase 2a trial 56 Phase 2a clinical 55 teduglutide 55 Torisel 55 Phase 1b trial 55 alvimopan 55 muraglitazar 55 PROPEL trial 55 temsirolimus 55 randomized clinical 55 Phase IIb clinical 55 non inferiority 55 RCTs 55 dose cohorts 55 vicriviroc 54 primary efficacy endpoint 54 SUTENT 54 tocilizumab 54 secondary endpoint 54 Phase 2b trial 54 Phase III randomized 54 Phase Ia 54 primary endpoint 54 rosuvastatin 54 Bronchitol 54 evaluable patients 54 rNAPc2 54 clinical trial 54 Secondary endpoints 54 fondaparinux 53 eltrombopag 53 bosentan 53 sapacitabine 53 Phase 2b study 53 peginterferon 53 phase 2a 53 daclizumab 53 Board DSMB 53 FOSRENOL R 53 pharmacokinetic studies 53 nilotinib 53 Phase IIb trial 53 Phase 1b clinical 53 ziprasidone 53 sustained virologic response 53 randomized controlled trials 53 abatacept 53 elagolix 53 lacosamide 53 FDG PET 53 CAPRISA 53 EORTC 52 multicentre 52 sunitinib 52 TORISEL 52 decitabine 52 Phase III clinical 52 HGS ETR1 52 Phase IIa clinical 52 Pharmacokinetic 52 LymphoStat B 52 cardiovascular morbidity 52 Phase III pivotal 52 Phase Ib 52 pharmacodynamics 52 primary endpoints 52 chronic angina 52 evaluable 52 rivaroxaban 52 clinically meaningful 52 FOLFIRI 52 CYT# 52 zoledronic acid